Skip to main content

Cannabis Central: MediPharm Labs Shows Impressive Q2 Performance On All Fronts - Stock Still Falls 16%

LABS financial report for Q2 suggests that MediPharm Labs may well continue its impressive performance on all fronts for the foreseeable future.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.